Introduction

Welcome to the IDSA Lyme Disease Case Study Course.  This interactive course consists of a series of case studies and is based on the IDSA guideline “The Clinical Assessment, Treatment and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis and Babesiosis.” The case studies are designed to educate clinicians regarding the proper diagnosis and treatment of Lyme disease and also provide an opportunity to better understand the IDSA guideline.  Additional references are included to enhance the learning experience.

The cases included in this course were written by expert faculty members, some of whom authored the guideline.  Each case is accredited for .25 CME credits. To receive CME credit, the learner must complete at least 4 of the 6 cases, score 70% correct or higher on the post-test, and complete the evaluation. A letter of completion is also available for non-physicians.

Learning Objectives

At the completion of this course, participants will be better able to:

• Evaluate and diagnose Lyme disease
• Utilize effective therapy to treat Lyme disease
• Review and interpret the IDSA guideline “The Clinical Assessment, Treatment and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis and Babesiosis.”

Faculty and Disclosures

AUTHORS

Janet Gilsdorf, MD, Professor and Director, Pediatric Medical Center, University of Michigan Medical Center; Nothing to disclose.
John Halperin, MD, Professor of Neurology, Mount Sinai School of Medicine; Expert testimony in medical malpractice cases related to Lyme disease.
Michael Lin, MD, MPH, Assistant Professor, Section of Infectious Diseases, Rush University Medical Center; Nothing to disclose.
Daniel Mendoza, MD, Infectious Diseases Fellow, Washington Hospital Center; Nothing to disclose.
Sunil Sood, MD, Chief, Pediatric Infectious Diseases, Northshore University Hospital; Nothing to disclose.

WORKGROUP

Edward Dominguez, MD, Medical Director, Methodist Transplant Physicians; Wyeth: Advisor/Consultant, Honoraria; Cubist & Astellas: Honoraria.
Durland Fish, MD, Professor, Department of Epidemiology and Public Health, Yale University; New York Medical College, CDC, USDA, G. Harold and Leila Y. Mathers Foundation, NIH: Research Grants.
Aaron Glatt, MD, President and CEO, New Island Hospital; Nothing to disclose.
George Mejicano, MD, Associate Professor of Medicine, University of Wisconsin School of Medicine and Public Health; Nothing to disclose.
Eugene Shapiro, MD, Professor of Pediatrics, Epidemiology & Public Health, and Investigative Medicine, Yale University; Metropolitan Life Insurance Company: Reviewing claims of disability related to Lyme disease; Served as an expert witness in medical-malpractice cases related to Lyme disease; SUNY Downstate: Honoraria.
Allen Steere, MD, Professor of Medicine, Harvard Medical School; NIH, The Dana Foundation, G. Harold and Leila Y. Mathers Foundation, CDC: Research Grants/Contracts.
Gary Wormser, MD, Chief of Infectious Diseases and Vice Chair Department of Medicine, New York Medical College; Department of Justice: Expert testimony in a medical malpractice case related to Lyme disease; Retained in other medical-malpractice cases involving Lyme disease; NIH, Bio-Rad, and DiaSorin: Research Grants; Merck, Astra Zeneca, and Pfizer.
Paul Mead, MD, Medical Officer, Centers for Disease Control and Prevention; Nothing to disclose.

MEDICAL EDITOR

Meri Pozo, PhD, GLOBEX; Nothing to disclose.

INDEPENDENT REVIEWERS

Paul Auwaerter, MD, Clinical Director, Division of Infectious Diseases, Johns Hopkins University School of Medicine; Expert testimony in medical malpractice cases related to Lyme disease.
Harry Gallis, MD, Consulting Professor of Medicine, Duke University Medical Center; Genentech: Advisor/Consultant; Fortis-Spectrum: Advisor/Consultant.

PLANNERS

Jennifer Padberg, MPH, Director of Clinical Affairs, Infectious Diseases Society of America; Nothing to disclose.
Rachel Shnekendorf, MPH, Senior Education Officer, Infectious Diseases Society of America: Nothing to disclose.